Your Global Market Access and HEOR partner
Decision-making empowered by people, data, and technology for the evolving healthcare landscape
DRG’s Global HEOR and Market Access capabilities combine deep domain expertise with innovative approaches to deliver tailored and actionable solutions to our clients across the full spectrum of the product development lifecycle.
Visit DRG’s Booth 1002 or schedule a meeting in advance to discuss how we can advance Global Access for your healthcare interventions!
Our Thought Leaders will be presenting on a wide range of topics, including patient reported outcomes, burden of disease, outcomes-based contracting, economic modelling and more. View our posters below:
May 20: 3:30 - 7pm (presenting 6:00 - 7:00)
Chris LaVallee: [PMH25] REAL-WORLD EVIDENCE INVESTIGATION ON HEALTHCARE UTILIZATION AND COST AMONG NEGATIVE SYMPTOM PATIENTS AND NON-NEGATIVE SYMPTOM PATIENTS WITH SCHIZOPHRENIA IN THE US
May 21: 10:30 - 2pm (presenting 12:45 - 1:45)
Yulia Privolnev: [PCN183] OBTAINING REIMBURSEMENT AND OPTIMIZING UPTAKE FOR ONCOLOGY AGENTS IN THE EU5: PAYER AND PRESCRIBER PERSPECTIVES ON THE POWER OF BIOMARKER-TARGETED THERAPIES IN NSCLC
Steve Reeves: [PB137] TREATMENT SWITCHING AND PERCEPTION OF PHYSICIAN INTERACTIONS IN RHEUMATOID ARTHRITIS: PATIENT PERSPECTIVES
May 22: 10:30 - 2pm (presenting 12:45 - 1:45)
Yulia Privolnev: [PBI26] SINK OR SWIM: HOW CAN SLE BIOLOGICS SUCCESSFULLY ACHIEVE OPTIMAL REIMBURSEMENT AND UPTAKE IN THE EU5?
May 22: 9:30 - 2pm (presenting 12:45 - 1:45)
Chris Marshall: [PNS11] PATIENT-CENTERED METHODS: CONSIDERATIONS FOR QUALITATIVE RESEARCH TO SUPPORT CONTENT VALIDITY WHEN DEVELOPING CLINICAL OUTCOME ASSESSMENT (COA) MEASURES APPROPRIATE FOR ADOLESCENT PATIENTS (AGED 12-17 YEARS OLD)